NANOG and acute myeloid leukemia: However, treatment of AML control cell line HL-60 with DNA methyltransferase inhibitor AZA promoted activation of the accordingly regulated homeobox gene NANOG but left MKX unchanged (Fig 2B) [45], discounting aberrant DNA demethylation in MKX deregulation in AML.